Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Chief Transformation Officer | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 20,232 |
Ending reported balance
After 2026-09-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-15 · Grant · Acquired 2,592 · Balance 21,443 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Row 2 · 2026-09-15 · Tax withholding · Disposed 320 · Balance 21,123 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 3 · 2026-09-15 · Tax withholding · Disposed 309 · Balance 20,814 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 4 · 2026-09-15 · Tax withholding · Disposed 274 · Balance 20,540 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 5 · 2026-09-16 · Tax withholding · Disposed 308 · Balance 20,232 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 17, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 308 | $272.46 | $83,917.68 |
DisclosureSEC source: 0001429863-26-000003 · wk-form4_1789676915.xml · nonDerivative · entry 5 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,232 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 274 | $275.09 | $75,374.66 |
DisclosureSEC source: 0001429863-26-000003 · wk-form4_1789676915.xml · nonDerivative · entry 4 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,540 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 309 | $275.09 | $85,002.81 |
DisclosureSEC source: 0001429863-26-000003 · wk-form4_1789676915.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,814 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 320 | $275.09 | $88,028.80 |
DisclosureSEC source: 0001429863-26-000003 · wk-form4_1789676915.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,123 F2 · kind: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:28 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,592 | $275.09 | $713,033.28 |
DisclosureSEC source: 0001429863-26-000003 · wk-form4_1789676915.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,443 F1 · kind: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 3,135 | $311.40 | $976,239.00 |
DisclosureSEC source: 0001628280-26-018540 · wk-form4_1773764619.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,851 F2 · shares: Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 7,076 | $311.40 | $2,203,466.40 |
DisclosureSEC source: 0001628280-26-018540 · wk-form4_1773764619.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,986 F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. Read SEC document |
| March 12, 2026 Filed Mar 12, 2026 21:46 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 5,160 | $309.00 | $1,594,440.00 |
DisclosureSEC source: 0001628280-26-017392 · wk-form4_1773351981.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,910 F1 · price: On March 12, 2026, Mr. Vroman sold an aggregate of 5160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $308.969 to $309.11. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| September 16, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 325 | $259.83 | $84,444.75 |
DisclosureSEC source: 0001429863-25-000005 · wk-form4_1758131351.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,070 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 16, 2025. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 2,608 | $258.83 | $675,028.64 |
DisclosureSEC source: 0001429863-25-000005 · wk-form4_1758131351.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,395 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 971 | $258.83 | $251,323.93 |
DisclosureSEC source: 0001429863-25-000005 · wk-form4_1758131351.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 F1 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:19 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,625 | $258.68 | $420,355.00 |
DisclosureSEC source: 0001156375-25-000056 · wk-form4_1742314766.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,758 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:19 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,668 | $258.68 | $948,838.24 |
DisclosureSEC source: 0001156375-25-000056 · wk-form4_1742314766.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,383 F1 · shares: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 14:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 5,066 | $250.00 | $1,266,500.00 |
DisclosureSEC source: 0001156375-25-000013 · wk-form4_1739541895.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,715 Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,088 | $218.53 | $674,820.64 |
DisclosureSEC source: 0001156375-24-000179 · wk-form4_1726614704.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,781 Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 23:11 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,292 | $216.99 | $280,351.08 |
DisclosureSEC source: 0001156375-24-000179 · wk-form4_1726614704.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,693 F1 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on September 15, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 104 | $217.50 | $22,620.00 |
DisclosureSEC source: 0001156375-24-000052 · wk-form4_1710861886.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,985 F3 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/15/2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,345 | $217.50 | $510,037.50 |
DisclosureSEC source: 0001156375-24-000052 · wk-form4_1710861886.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,089 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 5,292 | $217.50 | $1,151,010.00 |
DisclosureSEC source: 0001156375-24-000052 · wk-form4_1710861886.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,434 F1 · shares: Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. Read SEC document |
| September 16, 2023 Filed Sep 18, 2023 22:16 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 105 | $206.82 | $21,716.10 |
DisclosureSEC source: 0001156375-23-000164 · wk-form4_1695075400.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,142 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:16 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,010 | $206.82 | $208,888.20 |
DisclosureSEC source: 0001156375-23-000164 · wk-form4_1695075400.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,247 F1 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2023. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:16 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,264 | $206.82 | $675,060.48 |
DisclosureSEC source: 0001156375-23-000164 · wk-form4_1695075400.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,257 Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 17:51 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 108 | $187.21 | $20,218.68 |
DisclosureSEC source: 0001156375-23-000035 · wf-form4_167907544968733.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,993 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/2023. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 22:56 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 111 | $191.56 | $21,263.16 |
DisclosureSEC source: 0001156375-22-000282 · wf-form4_166362808201045.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,101 F2 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:56 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,540 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000282 · wf-form4_166362808201045.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,212 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:56 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 672 | $190.77 | $128,197.44 |
DisclosureSEC source: 0001156375-22-000282 · wf-form4_166362808201045.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,672 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022. Read SEC document |
| September 14, 2022 Filed Sep 15, 2022 21:49 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 142 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000240 · wf-form4_166327856955011.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,344 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. Read SEC document |
| September 14, 2022 Filed Sep 19, 2022 23:09 UTC Amendment | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 142 | $191.30 | $27,164.60 |
DisclosureSEC source: 0001156375-22-000293 · wf-form4a_166362897309529.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,344 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2022. F2 · price: This Form 4 is being amended to include the price at which shares were withheld for payment of taxes, which amount was inadvertently omitted from the original filing due to clerical error. Read SEC document |
| September 12, 2022 Filed Sep 13, 2022 15:10 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 750 | $201.41 | $151,057.50 |
DisclosureSEC source: 0001156375-22-000223 · wf-form4_166308182078456.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,486 Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 20:44 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 73 | $242.01 | $17,666.73 |
DisclosureSEC source: 0001156375-22-000133 · wf-form4_164754982632470.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,236 F3 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/2022. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 103 | $232.00 | $23,896.00 |
DisclosureSEC source: 0001156375-22-000133 · wf-form4_164754982632470.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:44 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 349 | $232.00 | $80,968.00 |
DisclosureSEC source: 0001156375-22-000133 · wf-form4_164754982632470.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Chief Transformation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,412 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 15:26 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 445 | $220.00 | $97,900.00 |
DisclosureSEC source: 0001156375-21-000181 · wf-form4_163673080403512.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,063 Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 19:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 117 | $188.69 | $22,076.73 |
DisclosureSEC source: 0001156375-21-000144 · wf-form4_163190691141169.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,508 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000122 · wf-form4_163181124073331.xml · nonDerivative · entry 4 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,625 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 264 | $188.96 | $49,885.44 |
DisclosureSEC source: 0001156375-21-000122 · wf-form4_163181124073331.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,253 F2 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 125 | $188.96 | $23,620.00 |
DisclosureSEC source: 0001156375-21-000122 · wf-form4_163181124073331.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,517 F2 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2021. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 16:54 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 88 | $188.85 | $16,618.80 |
DisclosureSEC source: 0001156375-21-000122 · wf-form4_163181124073331.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 F1 · shares: Mr. Ken Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2021. Read SEC document |
| March 16, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 78 | $207.12 | $16,155.36 |
DisclosureSEC source: 0001156375-21-000038 · edgardoc.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,730 F3 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 3/16/2021. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 387 | $209.09 | $80,917.83 |
DisclosureSEC source: 0001156375-21-000038 · edgardoc.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,808 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:27 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,316 | $209.09 | $275,162.44 |
DisclosureSEC source: 0001156375-21-000038 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,195 F1 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2018-2020. Read SEC document |
| November 02, 2020 Filed Nov 3, 2020 21:58 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,541 | $152.63 | $693,092.83 |
DisclosureSEC source: 0001156375-20-000117 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,879 Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 22:03 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 121 | $170.20 | $20,594.20 |
DisclosureSEC source: 0001156375-20-000111 · edgardoc.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,420 F1 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 143 | $168.10 | $24,038.30 |
DisclosureSEC source: 0001156375-20-000098 · edgardoc.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,417 F2 · shares: Ms. Kendal L Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 202 | $168.10 | $33,956.20 |
DisclosureSEC source: 0001156375-20-000098 · edgardoc.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,560 F2 · shares: Ms. Kendal L Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 22:03 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 3,124 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000111 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,541 Read SEC document |
| September 14, 2020 Filed Sep 17, 2020 01:33 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 95 | $166.08 | $15,777.60 |
DisclosureSEC source: 0001156375-20-000098 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,762 F1 · shares: Ms. Kendal L Vroman surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2020. Read SEC document |
| March 16, 2020 Filed Mar 17, 2020 20:41 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 5 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,857 Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 282 | $182.01 | $51,326.82 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 4 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,721 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 3 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,003 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.